Author:
Saleh Shadi,Abou Samra Clara,Jleilaty Stewart,Constantin Joanne,El Arnaout Nour,Dimassi Hani,Al-Bittar Dania
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference33 articles.
1. World Health Organization. How to develop and implement a national drug policy, Geneva. 2002.
http://www.who.int/management/background_4b.pdf
. Accessed Aug 2017.
2. Andersson K, Bergström G, Petzold MG, Carlsten A. Impact of a generic substitution reform on patients’ and society’s expenditure for pharmaceuticals. Health Policy. 2007;81(2):376–84.
3. Gerdtham U-G, Lundin D. Why did drug spending increase during the 1990s? Pharmacoeconomics. 2004;22(1):29–42.
4. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.
5. Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99(1):60–5.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献